BioCentury
ARTICLE | Clinical News

Cyclosporine: SANG began pivotal bioequivalence trials with its formulation of cyclosporine.

July 15, 1996 7:00 AM UTC

SangStat Medical Corp. (SANG), Menlo Patk, Calif. Product: Cyclosporine Indication: Chronic immunosuppression Status: SANG began pivotal bioequivalence trials with its formulation of cyclosporine. The...